Type 2 Diabetes

Various T2 factors create need for multiple treatment options.

Systemic review, network meta-analysis found treatment resulted in greatest reductions in HbA1c, fasting blood glucose, and body weight.

Nearly half of patients with stable A1c, who do not use insulin, found to be unnecessarily tested three to four times a year.

Safety, efficacy of these new classes of diabetic medication require more detailed investigation.

New study showed women accept disease, implement disease management more easily.

Type 1 indicates the processes of β-cell destruction that may ultimately lead to diabetes in which insulin is required for survival in order to prevent the development of ketoacidosis, coma, and death.

Diabetes in Control Publisher Steve Freed and Dr. Richard Bergman, founder and director of Diabetes and Obesity Research Institute, Biomedical Sciences at Cedars-Sinai in Los Angeles, discuss the ability to predict the development of type 2 diabetes and the role A1c might play in this prediction.

A known link between low testosterone levels and decreased insulin sensitivity could lead to a treatment for men with type 2.

To maintain the benefits while minimizing risk, consider patient risk factors when prescribing, and monitor for DKA and UTI.

Study finds insulin secretion returns to normal with one-gram fat loss.